A recently posted clinical trial suggests that Taro Pharmaceuticals is readying to gain approval to market Generic Metrogel 1%. Currently Generic Metrogel is only available in 0.75% strength.
Taro Pharmaceuticals in fact already markets a generic form of Metrogel – Metronidazole Gel USP, 0.75%
When the patent covering Metrogel 0.75% expired, Galderma changed the formulation, increased the concentration of metronidazole to 1% and now produces the best-known rosacea treatment, Metrogel 1%.
This is good news for rosacea suffers, who can only benefit from competition in the rosacea treatment staples market. Often rosacea sufferers come away from their first visit to the doctor and pharmacist with one thought – Why is this Metrogel so expensive?
Trial CT01513863 is listed to compare Taro Pharmaceutical’s Generic Metronidazole 1% Gel with Galderma’s Metrogel 1% (and also placebo).
Clinical Trial NCT01513863
A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multi-Site Clinical Study to Compare the Bioequivalence of Two Metronidazole 1% Topical Gel Formulations in Patients With Moderate to Severe Rosacea
Arm 1
Metronidazole Topical Gel 1%: Experimental
Intervention: Drug: Metronidazole Topical Gel 1%
Arm 2
Metronidazole Topical Gel 1% (Metrogel ): Active Comparator
Intervention: Drug: Metronidazole Topical Gel 1% (Metrogel)
Arm 3
Placebo: Placebo Comparator
Intervention: Drug: Placebo
Related Articles
- Generic Metrogel soon – Fougera
- Metrogel 1% Pump; for those who don’t like a Tube?
- Metronidazole (Metrogel, Flagyl) is a popular rosacea treatment
